Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1
出版年份 2018 全文链接
标题
Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1
作者
关键词
-
出版物
CELL PROLIFERATION
Volume -, Issue -, Pages e12514
出版商
Wiley
发表日期
2018-10-20
DOI
10.1111/cpr.12514
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- SREBP1-driven lipid desaturation supports clear cell renal cell carcinoma growth through regulation of NF-κB signaling
- (2018) Hao Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal cell carcinoma cells
- (2018) Yuwan Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- Resveratrol induces sumoylated COX-2-dependent anti-proliferation in human prostate cancer LNCaP cells
- (2018) Tsai-Mu Cheng et al. FOOD AND CHEMICAL TOXICOLOGY
- Resveratrol as MDR reversion molecule in breast cancer: An overview
- (2017) Nafiseh Sadat Alamolhodaei et al. FOOD AND CHEMICAL TOXICOLOGY
- Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer
- (2017) Ke Chen et al. Molecular Cancer
- Cancer stem cells: The root of tumor recurrence and metastases
- (2017) Claudia Peitzsch et al. SEMINARS IN CANCER BIOLOGY
- Effects of Resveratrol against Lung Cancer: In Vitro and In Vivo Studies
- (2017) Michael Yousef et al. Nutrients
- Metformin Inhibits Gemcitabine Induced Apoptosis in Pancreatic Cancer Cell Lines
- (2017) Dietmar Zechner et al. Journal of Cancer
- Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment
- (2017) Jeffrey Koury et al. Stem Cells International
- Pancreatic Cancer Chemoresistance to Gemcitabine
- (2017) Manoj Amrutkar et al. Cancers
- Gemcitabine treatment induces endoplasmic reticular (ER) stress and subsequently upregulates urokinase plasminogen activator (uPA) to block mitochondrial-dependent apoptosis in Panc-1 cancer stem-like cells (CSCs)
- (2017) Li Wang et al. PLoS One
- Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade
- (2016) Zhengle Zhang et al. CANCER LETTERS
- YAP Inhibition by Resveratrol via Activation of AMPK Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine
- (2016) Zhengdong Jiang et al. Nutrients
- Resveratrol in the treatment of pancreatic cancer
- (2015) Qinhong Xu et al. Annals of the New York Academy of Sciences
- Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth
- (2015) Chunming Cheng et al. CANCER CELL
- Ormeloxifene Suppresses Desmoplasia and Enhances Sensitivity of Gemcitabine in Pancreatic Cancer
- (2015) Sheema Khan et al. CANCER RESEARCH
- Gemcitabine resistance in pancreatic ductal adenocarcinoma
- (2015) Yoav Binenbaum et al. DRUG RESISTANCE UPDATES
- Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway
- (2015) WEI LI et al. ONCOLOGY REPORTS
- Concise Review: Stem Cells in Pancreatic Cancer: From Concept to Translation
- (2015) Deepak Raj et al. STEM CELLS
- SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism
- (2015) Yan Sun et al. TUMOR BIOLOGY
- Ginkgolic acid suppresses the development of pancreatic cancer by inhibiting pathways driving lipogenesis
- (2015) Jiguang Ma et al. Oncotarget
- Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy
- (2015) A Borah et al. Oncogenesis
- Overexpression of Nodal induces a metastatic phenotype in pancreatic cancer cells via the Smad2/3 pathway
- (2015) Wanxing Duan et al. Oncotarget
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Fatostatin Displays High Antitumor Activity in Prostate Cancer by Blocking SREBP-Regulated Metabolic Pathways and Androgen Receptor Signaling
- (2014) X. Li et al. MOLECULAR CANCER THERAPEUTICS
- Metabolism addiction in pancreatic cancer
- (2014) R Blum et al. Cell Death & Disease
- Resveratrol Inhibits the Epithelial-Mesenchymal Transition of Pancreatic Cancer Cells Via Suppression of the PI-3K/Akt/NF-κB Pathway
- (2013) Wei Li et al. CURRENT MEDICINAL CHEMISTRY
- Targeting cancer stem cells to suppress acquired chemotherapy resistance
- (2013) S J Vidal et al. ONCOGENE
- The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer
- (2013) C Hage et al. Cell Death & Disease
- Human pancreatic adenocarcinoma contains a side population resistant to gemcitabine
- (2012) Anke Van den broeck et al. BMC CANCER
- Expanding Roles for SREBP in Metabolism
- (2012) Wei Shao et al. Cell Metabolism
- Concise Review: Emerging Concepts in Clinical Targeting of Cancer Stem Cells
- (2011) Zeshaan A. Rasheed et al. STEM CELLS
- Comparative analysis of tumorbiology and CD133 positivity in primary and recurrent pancreatic ductal adenocarcinoma
- (2009) Thilo Welsch et al. CLINICAL & EXPERIMENTAL METASTASIS
- Clinical pharmacology and pharmacogenetics of gemcitabine
- (2009) Andrea Wong et al. DRUG METABOLISM REVIEWS
- SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth
- (2008) Thomas Porstmann et al. Cell Metabolism
- Gemcitabine Resistance in Pancreatic Cancer: Picking the Key Players
- (2008) M. P. Kim et al. CLINICAL CANCER RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started